brain metastases
Showing 1 - 25 of >10,000
Brain Metastases: Value ofLongitudinal Multimodal Approach
Recruiting
- Brain Metastases, Adult
-
Brest, FranceChu Brest
Sep 6, 2023
Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult, KRAS G12C Trial (JDQ443)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- +2 more
- (no location specified)
Aug 11, 2023
Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)
Not yet recruiting
- Lung Cancer
- +2 more
- Alectinib
- Stereotactic Radiosurgery
- (no location specified)
Aug 4, 2023
Brain Metastases, Radiotherapy Trial in Heidelberg (Preoperative Radiotherapy, Intraoperative Radiation, Postoperative
Not yet recruiting
- Brain Metastases
- Radiotherapy
- Preoperative Radiotherapy
- +2 more
-
Heidelberg, GermanyDepartment of Radiotherapy, University of Heidelberg
May 12, 2023
Breast Cancer, Brain Metastases, Radiotherapy Trial in Shanghai (Combination use of SRT with T-DXd)
Not yet recruiting
- Breast Cancer
- +2 more
- Combination use of SRT with T-DXd
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 14, 2023
Brain Metastases Trial (biological samples (blood test and lumbar puncture))
Not yet recruiting
- Brain Metastases
- biological samples (blood test and lumbar puncture)
- (no location specified)
May 4, 2023
Brain Metastases, Radionecrosis, Pulmonary Cancer Trial in Paris (MRI with CEST sequence, IVIM and ASL sequence)
Not yet recruiting
- Brain Metastases
- +2 more
- MRI with CEST sequence, IVIM and ASL sequence
-
Paris, FranceHôpital Bichat-Claude Bernard
Aug 3, 2023
Breast Cancer With Brain Metastases Trial in Wuhan (pyrotinib+capecitabine+bevacizumab)
Recruiting
- Breast Cancer With Brain Metastases
-
Wuhan, Hubei, ChinaTongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 22, 2023
Breast Cancer Brain Metastases Trial in Guangzhou (SPH4336 Tablets)
Not yet recruiting
- Breast Cancer Brain Metastases
- SPH4336 Tablets
-
Guangzhou, Guangdong, ChinaAffiliated Cancer Hospital, Sun Yat-sen University
May 24, 2023
NSCLC, EGFR Activating Mutation, Brain Metastases Trial in Beijing (TY-9591, Osimertinib)
Not yet recruiting
- NSCLC
- +2 more
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospitial,Chinese Academy of Medic
Jul 9, 2023
Brain Metastases, Radiotherapy, EGFR Activating Mutation Trial in Guangdong (brain radiotherapy, Almonertinib)
Recruiting
- Brain Metastases
- +2 more
- brain radiotherapy
- Almonertinib
-
Guangdong, Guangzhou, ChinaSun-Yat-Sen university
Mar 13, 2023
Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Shanghai (Pyrotinib Plus Capecitabine combined with brain
Active, not recruiting
- Breast Cancer
- +2 more
- Pyrotinib Plus Capecitabine combined with brain radiotherapy
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 14, 2023
Brain Metastases Trial in Houston (18F-Fluciclovine (Axumin), Pet Scan)
Not yet recruiting
- Brain Metastases
- 18F-Fluciclovine (Axumin)
- Pet Scan
-
Houston, TexasM D Anderson Cancer Center
Aug 23, 2023
Cancer, Metastasis, Metastatic Cancer Trial in Miami (Azeliragon, Stereotactic radiosurgery, Corticosteroid)
Not yet recruiting
- Cancer
- +4 more
- Azeliragon
- +2 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Mar 16, 2023
Breast Cancer, Brain Metastases Trial in New York (Brain Imaging with 18F-FES)
Not yet recruiting
- Breast Cancer
- Brain Metastases
- Brain Imaging with 18F-FES
-
New York, New YorkNew York-Presbyterian/Weill Cornell Medical Center
Oct 2, 2023
Brain Metastases, Adult Trial in Durham (Patritumab deruxtecan)
Not yet recruiting
- Brain Metastases, Adult
- Patritumab deruxtecan
-
Durham, North CarolinaDuke University Medical Center
Jan 19, 2023
Glioblastoma (GBM) Trial in Basel (Advanced diffusion-weighted MRI (ADW-MRI))
Recruiting
- Glioblastoma (GBM)
- Advanced diffusion-weighted MRI (ADW-MRI)
-
Basel, SwitzerlandUniversity Hospital Basel
Jun 21, 2023
Brain Metastases, Nonsmall Cell Lung Cancer Stage III Trial in Winston-Salem (MRI of the Brain, Blood draws, Quality of Life
Not yet recruiting
- Brain Metastases
- Nonsmall Cell Lung Cancer Stage III
- MRI of the Brain
- +2 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Cente
Jan 19, 2023
NSCLC Stage II, Bevacizumab, Immunotherapy Trial in Guangzhou (Serplulimab combined with bevacizumab and first-line chemo)
Not yet recruiting
- Non-small Cell Lung Cancer Stage II
- +3 more
- Serplulimab combined with bevacizumab and first-line chemotherapy
-
Guangzhou, Guangdong, ChinaLikun Chen
Apr 10, 2023
Non Small Cell Lung Cancer, Brain Metastases Trial (Cadonilimab)
Not yet recruiting
- Non Small Cell Lung Cancer
- Brain Metastases
- (no location specified)
Apr 2, 2023
Target Therapy for Brain Metastases With EGFR Mutation
Not yet recruiting
- Brain Metastases
- Surgery or Radiotherapy
- before or after target therapy
- (no location specified)
Nov 8, 2022
Brain Metastases, Adult Trial (Hypofractionated Radiosurgery (HSRS), Brain metastases surgical resection)
Not yet recruiting
- Brain Metastases, Adult
- Hypofractionated Radiosurgery (HSRS)
- Brain metastases surgical resection
- (no location specified)
Oct 4, 2022
Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))
Not yet recruiting
- Breast Cancer
- Metastatic Breast Cancer
- Trastuzumab-Deruxtecan (T-DXd)
- (no location specified)
Sep 20, 2023
Brain Metastases Trial in New York (18F-FCH PET Scan)
Completed
- Brain Metastases
- 18F-FCH PET Scan
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 15, 2022
Brain Metastases, Adult Trial in Heidelberg (post-operative stereotactic radiosurgery (SRS), Whole brain radiotherapy (WBRT))
Completed
- Brain Metastases, Adult
- post-operative stereotactic radiosurgery (SRS)
- Whole brain radiotherapy (WBRT)
-
Heidelberg, GermanyDepartment of Radiotherapy, University of Heidelberg
Nov 2, 2022